Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLA/Leucine and Metformin for Visceral Fat in Metabolic Syndrome
NCT02629627Phase 2Completed
- Sponsor
- Centro Universitario de Ciencias de la Salud
- Start
- Mar 2016
- Primary completion
- Mar 2017
01
Overview
Phase 2, randomised, double-blind trial in metabolic syndrome (4 arms), sponsored by Centro Universitario de Ciencias de la Salud. Primary endpoint: Visceral Fat Area at 8 weeks. Started Mar 2016; status: completed.
02
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT02629627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02629627.